Market Research Logo

Global Hospital-Acquired Infection Control Market 2017-2021

Global Hospital-Acquired Infection Control Market 2017-2021

About Hospital-Acquired Infection Control

HAIs, which are also called nosocomial infections, refer to a collection of conditions that a patient may develop when being treated in hospitals or other healthcare facilities. Modern healthcare settings use multiple devices to treat patients. These can be breeding grounds for microorganisms, which can have adverse effects on patient health. HAIs have caused a significant cost burden on patients and healthcare facilities.

Technavio’s analysts forecast the global hospital-acquired infection control market to grow at a CAGR of 4.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global hospital-acquired infection control market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of HAI products.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Hospital-Acquired Infection Control Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • GlaxoSmithKline
  • Merck
  • Pfizer
Other prominent vendors
  • 3M
  • Abbott Laboratories
  • AbbVie
  • Advanced Sterilization Products
  • Alere
  • Bayer
  • BD
  • bioMérieux
  • Cepheid
  • Getinge Group
  • Hoffmann La-Roche
  • Synergy Health
  • Xenex
Market driver
  • Increasing innovative measures to prevent HAIs
  • For a full, detailed list, view our report
Market challenge
  • Emergence of antibiotic resistance
  • For a full, detailed list, view our report
Market trend
  • Emergence of innovative techniques to remove biofilms
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Hospital-Acquired Infection Control Market 2017-2021

Technavio recognizes the following companies as the key players in the global hospital-acquired infection control market: AstraZeneca, GlaxoSmithKline, Merck, and Pfizer.

Other Prominent Vendors in the market are: 3M, Abbott Laboratories, AbbVie, Advanced Sterilization Products, Alere, Bayer, BD, bioMérieux, Cepheid, Getinge Group, Hoffmann La-Roche, Synergy Health, and Xenex.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is emergence of innovative techniques to remove biofilms. Biofilm refers to a collective layer of microorganisms that can form on the surface of a medical device or on any other area where a biological activity takes place. These layers attach to both biotic and abiotic surfaces. Hence, they can be found at the sites of HAIs.”

According to the report, one driver in the market is increasing innovative measures to prevent HAIs. With increasingly complex pathogens emerging in healthcare facilities and these microbes developing multiple antibiotic resistance, hospitals must use innovative methods to combat HAIs, which is a significant cost burden on the healthcare systems of countries. For instance, HAI infections cost approximately $35 billion annually in the US. Hence innovative measures are required to reduce the incidence of HAIs. The use of ultraviolet (UV) radiation to systematically disinfect hospitals is an innovative approach to control the prevalence of HAIs.

Further, the report states that one challenge in the market is emergence of antibiotic resistance. Antibiotic resistance refers to a microorganism becoming resistant to multiple antibiotics as it modifies itself when exposed to antimicrobial drugs. Microorganisms that develop resistance to antibiotics are referred to as superbugs. Improper hospital hygiene, unwanted or increased use of antibiotics, and emergence of genetic elements that adapt and enhance bacterial resistance mechanisms are the primary causes of antibiotic resistance.

Companies Mentioned

AstraZeneca, GlaxoSmithKline, Merck, Pfizer, 3M, Abbott Laboratories, AbbVie, Advanced Sterilization Products, Alere, Bayer, BD, bioMérieux, Cepheid, Getinge Group, Hoffmann La-Roche, Synergy Health, and Xenex.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Overview
  • Market landscape
    • Overview
      • Table Prevention, diagnosis, and treatment methods of HAIs
      • Table Global HAI control market: Overview 2016-2021
    • Market size and forecast
      • Table Global HAI control market 2016-2021 ($ million)
      • Table Factors impacting global HAI control market
      • Table Five forces analysis
  • Segmentation by infection type
    • Overview
      • Table Global HAI control market: Segmentation by infection type 2016 and 2021 (% share)
    • CAUTIs
      • Table Global HAI control market for CAUTIs 2016-2021 ($ million)
    • SSIs
      • Table Global HAI control market for SSIs 2016-2021 ($ million)
    • CLABSIs
      • Table Global HAI control market for CLABSIs 2016-2021 ($ million)
    • Respiratory infections
      • Table Global HAI control market for respiratory infections 2016-2021 ($ million)
  • Segmentation by end-user
    • Overview
      • Table Global HAI control market: Segmentation by end-user 2016 and 2021 (% share)
      • Table Global HAI control market: Overview of segmentation by end-user
    • Hospitals and ICUs
      • Table Global HAI control market by hospitals and ICUs 2016-2021 ($ million)
    • Outpatient care centers
      • Table Global HAI control market by outpatient care centers 2016-2021 ($ million)
    • LTCFs
      • Table Global HAI control market by LTCFs 2016-2021 ($ million)
    • Others
      • Table Global HAI control market by others 2016-2021 ($ million)
  • Segmentation by geography
    • Overview
      • Table Global HAI control market: Segmentation by geography 2016-2021 (% share)
      • Table Global HAI control market: Overview of segmentation by geography
    • Americas
      • Table HAI control market in Americas: Overview
      • Table HAI control market in Americas 2016-2021 ($ million)
    • EMEA
      • Table HAI control market in EMEA: Overview
      • Table HAI control market in EMEA 2016-2021 ($ million)
    • APAC
      • Table HAI control market in APAC: Overview
      • Table HAI control market in APAC 2016-2021 ($ million)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Factors contributing to infections among aging people
    • Market challenges
      • Table Annual cost of various types of HAIs (% share)
      • Table Infection preventionists: Roles in preventing HAIs
      • Table Types and number of positions for infection preventionists in US
  • Market trends
    • Emergence of innovative techniques to remove biofilms
    • Decrease in regulatory approvals of antibiotics
      • Table Discovery of antibiotics 1900-2010
      • Table Drugs for HAIs in clinical development
    • Focus on early diagnosis and preventive medicine
    • Cost burden of HAIs on patients and hospitals
  • Vendor landscape
    • Competitive scenario
      • Table Strategic success factors for vendors
  • Key vendor analysis
    • AstraZeneca
      • Table AstraZeneca: Profile
      • Table AstraZeneca: Strength analysis
      • Table AstraZeneca: Strategy assessment
      • Table AstraZeneca: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Profile
      • Table GlaxoSmithKline: Strength analysis
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Merck
      • Table Merck: Profile
      • Table Merck: Strength analysis
      • Table Merck: Strategy assessment
      • Table Merck Group opportunity assessment
    • Pfizer
      • Table Pfizer: Profile
      • Table Pfizer: Strength analysis
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report